Preferred Practice Pattern® guidelines are developed by the Academy's H. Dunbar Hoskins
Jr., MD Center for Quality Eye Care without any external financial support. Authors and …

Background Intraocular inflammation is an uncommon but potentially vision-threatening
adverse event related to anti-VEGF therapy. This is of increasing importance given both the …

Purpose To evaluate features and outcomes of eyes with retinal vasculitis and intraocular
inflammation (IOI) after intravitreal injection (IVI) of brolucizumab 6 mg/0.05 ml for treatment …

Endophthalmitis is a severe eye infection that may result in permanent loss of useful vision
in the affected eye. Most cases are exogenous and occur as a complication of cataract …

Intravitreal injections continue to be one of the most commonly performed procedures by
ophthalmologists. Although the injections are generally well tolerated, sight-threatening …

Purpose To expand understanding of presentation, diagnosis, and outcomes of hemorrhagic
occlusive retinal vasculitis (HORV). Design Retrospective case series. Participants Thirty-six …

Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents is a
commonly used therapy for numerous retinal diseases. The most commonly used of these …

Staphylococcus aureus is a major pathogen of the eye able to infect the tear duct, eyelid,
conjunctiva, cornea, anterior and posterior chambers, and the vitreous chamber. Of these …

Purpose To compare the postoperative endophthalmitis rate before and after initiation of
intracameral (IC) moxifloxacin prophylaxis for both phacoemulsification and sutureless …

Three cases of brolucizumab-associated retinal vasculitis treated with systemic and local steroid
therapy | Japanese Journal of Ophthalmology Skip to main content SpringerLink Account Menu …